![]() |
Volumn 29, Issue 6, 1997, Pages 2680-2683
|
Should hepatitis B immunoglobulin therapy be discontinued after HBV reinfection following liver transplantation?
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEPATITIS B ANTIBODY;
ADULT;
CLINICAL ARTICLE;
CONFERENCE PAPER;
FEMALE;
HEPATITIS B;
HUMAN;
IMMUNOTHERAPY;
LIVER FAILURE;
LIVER TRANSPLANTATION;
MALE;
MEDICAL DECISION MAKING;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
REINFECTION;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ADULT;
ANTIBODIES, VIRAL;
FEMALE;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMANS;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 0030868404
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(97)00554-X Document Type: Conference Paper |
Times cited : (3)
|
References (19)
|